May 28, 2015
More on Accountable Care
See which ACOs scored highest in each CMS quality benchmark
Slide 1 of 34
Slide 2 of 34
ACO-1: Getting timely care, appointments and information
Slide 3 of 34
ACO-2: How well your doctors communicate
Slide 4 of 34
ACO-3: Patients' rating of doctor
Slide 5 of 34
ACO-4: Access to specialists
Slide 6 of 34
ACO-5: Health promotion and education
Slide 7 of 34
ACO-6: Shared decision making
Slide 8 of 34
ACO-7: Health status/functional status
Slide 9 of 34
ACO-8: Risk standardized, all condition readmissions
Slide 10 of 34
ACO-9: ASC admissions: COPD or asthma in older adults
Slide 11 of 34
ACO-10: ASC admission: heart failure
Slide 12 of 34
ACO-11: Percent of PCPs who qualified for EHR incentive payment
Slide 13 of 34
ACO-12: Medication reconciliation
Slide 14 of 34
ACO 13: Falls: Screening for fall risk
Slide 15 of 34
ACO-14: Influenza immunization
Slide 16 of 34
ACO-15: Pneumococcal vaccination
Slide 17 of 34
ACO-16: Adult weight screening and follow-up
Slide 18 of 34
ACO-17: Tobacco use assessment and cessation intervention
Slide 19 of 34
ACO-18: Depression screening
Slide 20 of 34
ACO-19: Colorectal cancer screening
Slide 21 of 34
ACO-20: Mammography screening
Slide 22 of 34
ACO-21: Proportion of adults who had blood pressure screened in past 2 years
Slide 23 of 34
ACO-22: Hemoglobin A1c control (HbA1c) (<8 percent)
Slide 24 of 34
ACO-23: Low Density Lipoprotein (LDL) (< 100 mg/dL)
Slide 25 of 34
ACO-24: Blood pressure (BP) (< 140/90)
Slide 26 of 34
ACO-25: Tobacco non use
Slide 27 of 34
ACO-26: Aspirin use
Slide 28 of 34
ACO-27: Percent of beneficiaries with diabetes whose HbA1c in poor control (> 9 percent)
Slide 29 of 34
ACO-28: Percent of beneficiaries with hypertension whose BP (< 140/90)
Slide 30 of 34
ACO-29: Percent of beneficiaries with IVD with complete lipid profile and LDL control (< 100mg/dl)
Slide 31 of 34
ACO-30: Percent of beneficiaries with IVD who use aspirin or other antithrombotic
Slide 32 of 34
ACO-31: Beta-blocker therapy for LVSD
Slide 33 of 34
ACO-32: Drug therapy for lowering LDL cholesterol
Slide 34 of 34
ACO-33: ACE Inhibitor or ARB Ttherapy for patients with CAD and diabetes and/or LVSD